KDR and neoplasm: The suppression of VEGF expression by VEGF neutralizing antibody inhibits tumour growth and metastasis,8 and an increasing number of drugs, such as bevacizumab and sunitinib, which target VEGF and VEGFR, have been developed.9, 10, 11, 12